{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:32:39Z","timestamp":1791689559172,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022502","name":"Mereo BioPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteogenesis imperfecta (OI) is a rare, heritable connective tissue disorder associated with a variety of symptoms, that affect individuals\u2019 quality of life (QoL) and can be associated with increased healthcare resource use. While some aspects of OI are well studied, others remain poorly understood. Therefore, the IMPACT survey aimed to elucidate the humanistic, clinical and economic burden of OI on individuals with OI, their families, caregivers and wider society.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed an international mixed methods online survey in eight\u00a0languages (fielded July\u2013September 2021), aimed at adults (aged\u2009\u2265\u200918\u00a0years) or adolescents (aged\u2009\u2265\u200912\u201317\u00a0years) with OI, caregivers (with or without OI) of individuals with OI and other close relatives. All respondents provided data on themselves; caregivers additionally provided data on individuals in their care by proxy. Data were cleaned, coded, and analysed using the pandas Python software package and Excel.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>IMPACT collected 2208 eligible questionnaires (covering 2988 individuals of whom 2312 had OI) including 1290 non-caregiver adults with OI, 92 adolescents with OI, 150 caregiver adults with OI, 560 caregivers for individuals with OI, 116 close relatives and 780 proxy care-recipients with OI. Most individuals with OI (direct or proxy) described their OI as moderate (41\u201352% across populations) and reported OI type 1 (33\u201338%). Pain (72\u201382%) was the most reported clinical condition experienced in the past 12\u00a0months and was also most frequently rated as severely or moderately impactful. Further, among adults, 67% reported fatigue, 47% scoliosis, and 46% sleep disturbance; in adolescents, fatigue affected 65%, scoliosis and other bone problems 60%, and mental health problems 46%; in children, fractures were common in\u00a067%, fatigue in 47%, and dental problems in 46%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>IMPACT has generated an extensive dataset on the experience of individuals with OI, their caregivers and relatives. We found that, irrespective of age, individuals with OI experience numerous and evolving symptoms that affect their QoL; however, pain and fatigue are consistently present. Upcoming analyses will provide further insights into the economic impact, healthcare journey and caregiver wellbeing, aiming to contribute to improved treatment and care for the OI community.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03126-9","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:01:42Z","timestamp":1711011702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The IMPACT survey: a mixed methods study to understand the experience of children, adolescents and adults with osteogenesis imperfecta and their caregivers"],"prefix":"10.1186","volume":"19","author":[{"given":"Ingunn","family":"Westerheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco","family":"van Welzenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Lande","family":"Wekre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Bober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-0579","authenticated-orcid":false,"given":"Maria","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"3126_CR1","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"key":"3126_CR2","unstructured":"Folkestad L. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark. Dan Med J. 2018; 65(4)."},{"key":"3126_CR3","unstructured":"Bishop N. Osteogenesis Imperfecta. In: Orphanet encyclopedia. 2021."},{"issue":"4","key":"3126_CR4","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-20-0299","volume":"183","author":"R Marom","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R. Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol. 2020;183(4):R95-r106.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3126_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","volume":"31","author":"V Rossi","year":"2019","unstructured":"Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019;31(6):708\u201315.","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"3126_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.dhjo.2018.12.003","volume":"12","author":"M Hill","year":"2019","unstructured":"Hill M, et al. Exploring the impact of Osteogenesis Imperfecta on families: a mixed-methods systematic review. Disabil Health J. 2019;12(3):340\u20139.","journal-title":"Disabil Health J"},{"issue":"1","key":"3126_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-023-02643-3","volume":"18","author":"D Mc Donald","year":"2023","unstructured":"Mc Donald D, et al. Systematic review of health related-quality of life in adults with osteogenesis imperfecta. Orphanet J Rare Dis. 2023;18(1):36.","journal-title":"Orphanet J Rare Dis"},{"key":"3126_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2431-13-153","volume":"13","author":"MJ Dogba","year":"2013","unstructured":"Dogba MJ, et al. The impact of severe osteogenesis imperfecta on the lives of young patients and their parents\u2014a qualitative analysis. BMC Pediatr. 2013;13:153.","journal-title":"BMC Pediatr"},{"issue":"1","key":"3126_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-023-02627-3","volume":"18","author":"M Rapoport","year":"2023","unstructured":"Rapoport M, et al. The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review. Orphanet J Rare Dis. 2023;18(1):34.","journal-title":"Orphanet J Rare Dis"},{"key":"3126_CR10","doi-asserted-by":"crossref","unstructured":"Murphy A, Howard A, Sochett E. Financial burden in families of children with osteogenesis imperfecta (OI). 8th International. 2017.","DOI":"10.1530\/boneabs.6.P197"},{"key":"3126_CR11","doi-asserted-by":"crossref","unstructured":"Tsimicalis A et al. Use of Netnography to Understand GoFundMe(\u00ae) crowdfunding profiles posted for individuals and families of children with osteogenesis imperfecta. Healthcare. 2022; 10(8).","DOI":"10.3390\/healthcare10081451"},{"issue":"3","key":"3126_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000321767","volume":"14","author":"DE Dye","year":"2011","unstructured":"Dye DE, et al. The impact of single gene and chromosomal disorders on hospital admissions of children and adolescents: a population-based study. Public Health Genomics. 2011;14(3):153\u201361.","journal-title":"Public Health Genomics"},{"issue":"10","key":"3126_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/jp.2016.111","volume":"36","author":"J Ruiter-Ligeti","year":"2016","unstructured":"Ruiter-Ligeti J, et al. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study. J Perinatol. 2016;36(10):828\u201331.","journal-title":"J Perinatol"},{"key":"3126_CR14","doi-asserted-by":"crossref","unstructured":"Darb\u00e0 J, Mars\u00e0 A. Hospital incidence, management and direct cost of osteogenesis imperfecta in Spain: a retrospective database analysis. J Med Econ, 2020; 1\u20136.","DOI":"10.1080\/13696998.2020.1834402"},{"issue":"1","key":"3126_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/BCO.0000000000000805","volume":"31","author":"CM Belyea","year":"2020","unstructured":"Belyea CM, Knox JB. Spinal fusion in children with osteogenesis imperfecta: a nationwide retrospective comparative cohort study over a 12-year period. Current Orthopaedic Practice. 2020;31(1):72\u20135.","journal-title":"Current Orthopaedic Practice"},{"key":"3126_CR16","doi-asserted-by":"crossref","unstructured":"Kolovos S, Javaid MK. Hospital admissions of patients with osteogenesis imperfecta in the English NHS. Osteoporosis 2020; ora.ox.ac.uk.","DOI":"10.1007\/s00198-020-05755-9"},{"issue":"2","key":"3126_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/BPO.0b013e31803179e2","volume":"27","author":"MG Vitale","year":"2007","unstructured":"Vitale MG, et al. Osteogenesis imperfecta: determining the demographics and the predictors of death from an inpatient population. J Pediatr Orthop. 2007;27(2):228\u201332.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"3126_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ajmg.a.37377","volume":"170a","author":"N Dahan-Oliel","year":"2016","unstructured":"Dahan-Oliel N, et al. Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet A. 2016;170a(1):62\u201376.","journal-title":"Am J Med Genet A"},{"key":"3126_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-12-54","volume":"12","author":"CL Hill","year":"2014","unstructured":"Hill CL, Baird WO, Walters SJ. Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based study. Health Qual Life Outcomes. 2014;12:54.","journal-title":"Health Qual Life Outcomes"},{"key":"3126_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-015-0362-2","volume":"10","author":"LL Tosi","year":"2015","unstructured":"Tosi LL, et al. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis. 2015;10:146.","journal-title":"Orphanet J Rare Dis"},{"key":"3126_CR21","doi-asserted-by":"crossref","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A, 2014; 164a(6): 1470\u201381.","DOI":"10.1002\/ajmg.a.36545"},{"key":"3126_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020281","author":"S Storoni","year":"2023","unstructured":"Storoni S, et al. From genetics to clinical implications: a study of 675 Dutch Osteogenesis imperfecta patients. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13020281.","journal-title":"Biomolecules"},{"issue":"5","key":"3126_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/cts.12783","volume":"13","author":"L Zhytnik","year":"2020","unstructured":"Zhytnik L, et al. Inter-and intrafamilial phenotypic variability in individuals with collagen-related osteogenesis imperfecta. Clin Transl Sci. 2020;13(5):960\u201371.","journal-title":"Clin Transl Sci"},{"issue":"5B","key":"3126_CR24","first-page":"113","volume":"15","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser. 1979;15(5B):113\u201329.","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"10","key":"3126_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/000348940211101014","volume":"111","author":"K Kuurila","year":"2002","unstructured":"Kuurila K, et al. Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey. Ann Otol Rhinol Laryngol. 2002;111(10):939\u201346.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1\u20132","key":"3126_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.drugalcdep.2012.05.014","volume":"126","author":"B Maclennan","year":"2012","unstructured":"Maclennan B, et al. Non-response bias in a community survey of drinking, alcohol-related experiences and public opinion on alcohol policy. Drug Alcohol Depend. 2012;126(1\u20132):189\u201394.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"3126_CR27","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2759","volume":"16","author":"Y Khazaal","year":"2014","unstructured":"Khazaal Y, et al. Does self-selection affect samples\u2019 representativeness in online surveys? An investigation in online video game research. J Med Internet Res. 2014;16(7): e164.","journal-title":"J Med Internet Res"},{"key":"3126_CR28","doi-asserted-by":"crossref","unstructured":"Gooijer K et al. A baseline measurement of quality of life in 322 adults with osteogenesis imperfecta. JBMR Plus, 2020.","DOI":"10.1002\/jbm4.10416"},{"key":"3126_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pedn.2020.06.009","volume":"55","author":"S Wiggins","year":"2020","unstructured":"Wiggins S, Kreikemeier R, Struwe L. Parents\u2019 perceptions of health-related quality of life of children diagnosed with osteogenesis imperfecta. J Pediatr Nurs. 2020;55:75\u201382.","journal-title":"J Pediatr Nurs"},{"issue":"19","key":"3126_CR30","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1080\/09638288.2017.1334236","volume":"40","author":"MCD Santos","year":"2018","unstructured":"Santos MCD, et al. Family experience with osteogenesis imperfecta type 1: the most distressing situations. Disabil Rehabil. 2018;40(19):2281\u20137.","journal-title":"Disabil Rehabil"},{"key":"3126_CR31","doi-asserted-by":"crossref","unstructured":"Orlando G et al. Physical function in UK adults with osteogenesis imperfecta: a cross-sectional analysis of the RUDY study. Osteoporos Int. 2020.","DOI":"10.1007\/s00198-020-05537-3"},{"issue":"9","key":"3126_CR32","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1651-2227.2005.tb02082.x","volume":"94","author":"P Zack","year":"2005","unstructured":"Zack P, et al. Fracture and non-fracture pain in children with osteogenesis imperfecta. Acta Paediatr. 2005;94(9):1238\u201342.","journal-title":"Acta Paediatr"},{"issue":"1","key":"3126_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12891-022-05825-5","volume":"23","author":"AH Provenzano","year":"2022","unstructured":"Provenzano AH, \u00c5str\u00f6m E, L\u00f6wing K. Exploring pain interference and self-perceived health status in children with osteogenesis imperfecta - a cross-sectional study. BMC Musculoskelet Disord. 2022;23(1):876.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"3126_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13023-019-1004-x","volume":"14","author":"LL Tosi","year":"2019","unstructured":"Tosi LL, et al. Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study. Orphanet J Rare Dis. 2019;14(1):23.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3126_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2648.2008.04694.x","volume":"63","author":"H Zhou","year":"2008","unstructured":"Zhou H, Roberts P, Horgan L. Association between self-report pain ratings of child and parent, child and nurse and parent and nurse dyads: meta-analysis. J Adv Nurs. 2008;63(4):334\u201342.","journal-title":"J Adv Nurs"},{"issue":"8","key":"3126_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejpain.2010.01.005","volume":"14","author":"LL Cohen","year":"2010","unstructured":"Cohen LL, Vowles KE, Eccleston C. Adolescent chronic pain-related functioning: concordance and discordance of mother-proxy and self-report ratings. Eur J Pain. 2010;14(8):882\u20136.","journal-title":"Eur J Pain"},{"key":"3126_CR37","doi-asserted-by":"crossref","unstructured":"Waters E, Stewart-Brown S, Fitzpatrick R. Agreement between adolescent self-report and parent reports of health and well-being: results of an epidemiological study. Child Care, Health Develop, 2003; 29(6): 501\u20139.","DOI":"10.1046\/j.1365-2214.2003.00370.x"},{"issue":"1","key":"3126_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2458-6-276","volume":"6","author":"GMB Sundblad","year":"2006","unstructured":"Sundblad GMB, Saartok T, Engstr\u00f6m LMT. Child\u2014parent agreement on reports of disease, injury and pain. BMC Public Health. 2006;6(1):276.","journal-title":"BMC Public Health"},{"key":"3126_CR39","doi-asserted-by":"crossref","unstructured":"Kr\u00f6ner-Herwig B et al. Agreement of parents and children on characteristics of pediatric headache, other pains, somatic symptoms, and depressive symptoms in an epidemiologic study. Clin J Pain, 2009; 25(1).","DOI":"10.1097\/AJP.0b013e31817fc62d"},{"issue":"1","key":"3126_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2014\/736053","volume":"19","author":"TR Vetter","year":"2014","unstructured":"Vetter TR, et al. Patient versus parental perceptions about pain and disability in children and adolescents with a variety of chronic pain conditions. Pain Res Manag. 2014;19(1):7\u201314.","journal-title":"Pain Res Manag"},{"issue":"1","key":"3126_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12998-016-0104-0","volume":"24","author":"SJ Kamper","year":"2016","unstructured":"Kamper SJ, Dissing KB, Hestbaek L. Whose pain is it anyway? Comparability of pain reports from children and their parents. Chiropractic Manual Ther. 2016;24(1):24.","journal-title":"Chiropractic Manual Ther"},{"issue":"3","key":"3126_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/jspn.12316","volume":"26","author":"KE Montgomery","year":"2021","unstructured":"Montgomery KE, et al. Comparison of child self-report and parent proxy-report of symptoms: results from a longitudinal symptom assessment study of children with advanced cancer. J Spec Pediatr Nurs. 2021;26(3): e12316.","journal-title":"J Spec Pediatr Nurs"},{"issue":"12","key":"3126_CR43","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/jbmr.2895","volume":"31","author":"L Folkestad","year":"2016","unstructured":"Folkestad L, et al. Mortality and causes of death in patients with osteogenesis imperfecta: a register-based nationwide cohort study. J Bone Miner Res. 2016;31(12):2159\u201366.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"3126_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jped.2018.12.008","volume":"96","author":"G Martins","year":"2020","unstructured":"Martins G, et al. Bladder and bowel symptoms experienced by children with osteogenesis imperfecta. J Pediatr (Rio J). 2020;96(4):472\u20138.","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"3126_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/pri.1546","volume":"18","author":"V Balkefors","year":"2013","unstructured":"Balkefors V, et al. Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta. Physiother Res Int. 2013;18(4):203\u201311.","journal-title":"Physiother Res Int"},{"issue":"1","key":"3126_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","volume":"11","author":"L Forestier-Zhang","year":"2016","unstructured":"Forestier-Zhang L, et al. Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis. 2016;11(1):160.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"3126_CR47","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/jor.20871","volume":"27","author":"A Graf","year":"2009","unstructured":"Graf A, et al. Gait characteristics and functional assessment of children with type I osteogenesis imperfecta. J Orthop Res. 2009;27(9):1182\u201390.","journal-title":"J Orthop Res"},{"issue":"1","key":"3126_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12887-018-1077-z","volume":"18","author":"AP Vanz","year":"2018","unstructured":"Vanz AP, et al. Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL\u2122. BMC Pediatr. 2018;18(1):95.","journal-title":"BMC Pediatr"},{"issue":"7","key":"3126_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jama.1988.03410070057028","volume":"260","author":"K Kroenke","year":"1988","unstructured":"Kroenke K, et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. Jama. 1988;260(7):929\u201334.","journal-title":"Jama"},{"issue":"9","key":"3126_CR50","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1176\/appi.ajp.157.9.1492","volume":"157","author":"P Skapinakis","year":"2000","unstructured":"Skapinakis P, Lewis G, Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Am J Psychiatry. 2000;157(9):1492\u20138.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3126_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13023-018-0971-7","volume":"13","author":"H Arponen","year":"2018","unstructured":"Arponen H, et al. Is sleep apnea underdiagnosed in adult patients with osteogenesis imperfecta? -a single-center cross-sectional study. Orphanet J Rare Dis. 2018;13(1):231.","journal-title":"Orphanet J Rare Dis"},{"key":"3126_CR52","doi-asserted-by":"crossref","unstructured":"Hill C et al. Sleep-related problems in children with osteogenesis imperfecta. 2019: bmjopenrespres.bmj.com.","DOI":"10.1136\/bmjresp-2019-bssconf.15"},{"key":"3126_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2019.05.005","volume":"123","author":"SM McCallum","year":"2019","unstructured":"McCallum SM, et al. Associations of fatigue and sleep disturbance with nine common mental disorders. J Psychosom Res. 2019;123: 109727.","journal-title":"J Psychosom Res"},{"issue":"11","key":"3126_CR54","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1177\/0004867412457997","volume":"46","author":"PJ Batterham","year":"2012","unstructured":"Batterham PJ, Glozier N, Christensen H. Sleep disturbance, personality and the onset of depression and anxiety: prospective cohort study. Aust N Z J Psychiatry. 2012;46(11):1089\u201398.","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"3126_CR55","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.5665\/sleep.2810","volume":"36","author":"PK Alvaro","year":"2013","unstructured":"Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 2013;36(7):1059\u201368.","journal-title":"Sleep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03126-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T20:01:45Z","timestamp":1711051305000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03126-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3126"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03126-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethics approval exemption was granted by Pearl IRB, Indianapolis, IN, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SP and MR are employees of Wickenstones Ltd, Abingdon, United Kingdom. Wickenstones. MB and CR have received payments for their contributions to the present manuscript. MB has received grants and from Ultragenyx Pharmaceuticals Inc, Novato, USA. and the Osteogenesis Imperfecta Foundation. TH serves as the Chief Executive Officer of the Osteogenesis Imperfecta Foundation and has received unrestricted educational grants from Mereo BioPharma Group London, United Kingdom and Ultragenyx Pharmaceuticals Inc, Novato, USA. OS has participated in a national advisory board for Mereo BioPharma Group London, United Kingdom. FR has received study contracts for experimental preclinical studies with Precithera Inc, Quebec, Canada, Mesentech Inc, Vancouver, Canada and Catabasis Pharmaceuticals Inc, Cambridge, USA. He has participated in advisory boards for Ultragenyx Pharmaceuticals Inc, Novato, USA, Sanofi S.A. Paris, France, Novartis International AG, Basel, Switzerland and Mereo BioPharma Group, London, United Kingdom. FR has received a speaker fee from Ultragenyx Pharmaceuticals Inc, Novato, USA for a lecture and received a donation of experimental drugs for a preclinical study from Acceleron Pharma Inc, Cambridge, USA. CR received an institutional grant from and has been a speaker for BioMarin Pharmaceuticals Inc, Novato, California, has participated in advisory boards for Ultragenyx Pharmaceuticals Inc, Novato, USA. She has received an institutional grant from and is a consultant for Nextcure, Beltville, MD, USA. CR sits on the board of directors of the Osteogenesis Imperfecta Foundation. CR has also participated in an advisory board for Mereo BioPharma Group, London, United Kingdom. TW and IW hold leadership positions in the Osteogenesis Imperfecta Federation Europe, which has received grants from Mereo BioPharma Group, London, United Kingdom (unrestricted), Ultragenyx Pharmaceuticals Inc, Novato, USA (restricted grant for a conference), Quince Therapeutics Inc, San Francisco, CA, USA (donation for a conference), UCB (restricted grant to conference), Angitia Biopharmaceuticals Inc., Woodland Hills, CA, USA (donation to conference), Azafaros BV, Naarden, the Netherlands (donation to conference), Alexion Inc. Boston, MA, USA, (sponsorship of conference); Pega Medical Inc, Laval, Quebec, Canada (donation), Sanofi S.A. Paris, France (payment to IW for engagement in steering committee; donated to OIFE). IW has also received payment as a panellist from Takeda, Tokyo, Japan.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}